{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:33:28Z","timestamp":1788910408019,"version":"build-2803163510"},"reference-count":56,"publisher":"WHO Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. World Health Organ."],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.2471\/blt.17.198879","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T15:17:18Z","timestamp":1514387838000},"page":"59-65","source":"Crossref","is-referenced-by-count":69,"title":["Praziquantel for the treatment of schistosomiasis during human pregnancy"],"prefix":"10.2471","volume":"96","author":[{"given":"Jennifer F","family":"Friedman","sequence":"first","affiliation":[{"name":"Center for International Health Research at Rhode Island Hospital, 55 Claverick Street, Suite 101, Providence, RI 02903, United States of America (USA)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remigio M","family":"Olveda","sequence":"additional","affiliation":[{"name":"Department of Immunology, Research Institute for Tropical Medicine, Manila, Philippines."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H","family":"Mirochnick","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Boston University School of Medicine, Boston, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya L","family":"Bustinduy","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M","family":"Elliott","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1305","published-online":{"date-parts":[[2017,11,27]]},"reference":[{"issue":"9936","key":"key-10.2471\/BLT.17.198879-201712271617-R1","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis.","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"key-10.2471\/BLT.17.198879-201712271617-R2","unstructured":"Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/43545\/1\/9241547103_eng.pdf[cited 2017 Nov 20]."},{"issue":"9470","key":"key-10.2471\/BLT.17.198879-201712271617-R3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)66457-4","article-title":"Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis.","volume":"365","author":"King","year":"2005","journal-title":"Lancet"},{"issue":"10100","key":"key-10.2471\/BLT.17.198879-201712271617-R4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease study 2016.","volume":"390","author":"Naghavi","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"key-10.2471\/BLT.17.198879-201712271617-R5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jn\/136.1.183","article-title":"Nutritional status improves after treatment of Schistosoma japonicum-infected children and adolescents.","volume":"136","author":"Coutinho","year":"2006","journal-title":"J Nutr"},{"issue":"3","key":"key-10.2471\/BLT.17.198879-201712271617-R6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/430929","article-title":"Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines.","volume":"192","author":"Coutinho","year":"2005","journal-title":"J Infect Dis"},{"issue":"5","key":"key-10.2471\/BLT.17.198879-201712271617-R7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4269\/ajtmh.2005.72.527","article-title":"Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines.","volume":"72","author":"Friedman","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"key-10.2471\/BLT.17.198879-201712271617-R8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4269\/ajtmh.1992.46.571","article-title":"Child growth and schistosomiasis japonica in northeastern Leyte, the Philippines: cross-sectional results.","volume":"46","author":"McGarvey","year":"1992","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"key-10.2471\/BLT.17.198879-201712271617-R9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4269\/ajtmh.1996.54.498","article-title":"Schistosomiasis japonica and childhood nutritional status in northeastern Leyte, the Philippines: a randomized trial of praziquantel versus placebo.","volume":"54","author":"McGarvey","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"key-10.2471\/BLT.17.198879-201712271617-R10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1086\/314686","article-title":"Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths.","volume":"179","author":"Olds","year":"1999","journal-title":"J Infect Dis"},{"issue":"4","key":"key-10.2471\/BLT.17.198879-201712271617-R11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4269\/ajtmh.1993.48.547","article-title":"Child growth, nutritional status, and schistosomiasis japonica in Jiangxi, People\u2019s Republic of China.","volume":"48","author":"McGarvey","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4269\/ajtmh.1990.43.170","article-title":"Metrifonate or praziquantel treatment improves physical fitness and appetite of Kenyan schoolboys with Schistosoma haematobium and hookworm infections.","volume":"43","author":"Latham","year":"1990","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"key-10.2471\/BLT.17.198879-201712271617-R13","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4269\/ajtmh.2006.75.720","article-title":"Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection.","volume":"75","author":"Coutinho","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ajcn\/83.2.371","article-title":"Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines 1.","volume":"83","author":"Leenstra","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"key-10.2471\/BLT.17.198879-201712271617-R15","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1128\/IAI.00757-06","article-title":"Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation.","volume":"74","author":"Leenstra","year":"2006","journal-title":"Infect Immun"},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.2005.72.115","article-title":"Schistosoma japonicum and occult blood loss in endemic villages in Leyte, the Philippines.","volume":"72","author":"Kanzaria","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"key-10.2471\/BLT.17.198879-201712271617-R17","doi-asserted-by":"publisher","first-page":"e2542","DOI":"10.1371\/journal.pntd.0002542","article-title":"Fecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection.","volume":"7","author":"Bustinduy","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"key-10.2471\/BLT.17.198879-201712271617-R18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/ije\/20.3.787","article-title":"Morbidity due to Schistosoma mansoni among sugar-cane cutters in Zimbabwe.","volume":"20","author":"Ndamba","year":"1991","journal-title":"Int J Epidemiol"},{"issue":"4","key":"key-10.2471\/BLT.17.198879-201712271617-R19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4269\/ajtmh.2012.12-0059","article-title":"Use of fecal occult blood tests as epidemiologic indicators of morbidity associated with intestinal schistosomiasis during preventive chemotherapy in young children.","volume":"87","author":"Betson","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"key-10.2471\/BLT.17.198879-201712271617-R20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/156482650602700101","article-title":"Determinants of anemia among pregnant women in Mali.","volume":"27","author":"Ayoya","year":"2006","journal-title":"Food Nutr Bull"},{"issue":"1","key":"key-10.2471\/BLT.17.198879-201712271617-R21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.trstmh.2005.06.024","article-title":"Schistosoma mansoni in pregnancy and associations with anaemia in northwest Tanzania.","volume":"100","author":"Ajanga","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1473-3099(15)00345-X","article-title":"Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial.","volume":"16","author":"Olveda","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"key-10.2471\/BLT.17.198879-201712271617-R23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","article-title":"The global status of schistosomiasis and its control.","volume":"77","author":"Chitsulo","year":"2000","journal-title":"Acta Trop"},{"issue":"8","key":"key-10.2471\/BLT.17.198879-201712271617-R24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.trstmh.2005.09.010","article-title":"Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel.","volume":"100","author":"Kjetland","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"key-10.2471\/BLT.17.198879-201712271617-R25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.aids.0000210614.45212.0a","article-title":"Association between genital schistosomiasis and HIV in rural Zimbabwean women.","volume":"20","author":"Kjetland","year":"2006","journal-title":"AIDS"},{"key":"key-10.2471\/BLT.17.198879-201712271617-R26","unstructured":"Biltricide tablets (praziquantel). Wayne: Bayer HealthCare Pharmaceuticals; 2014. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/018714s013lbl.pdf[cited 2017 Nov 15]."},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R27","first-page":"201","article-title":"The toxicological profile of praziquantel in comparison to other anthelminthic drugs.","volume":"57","author":"Frohberg","year":"1989","journal-title":"Acta Leiden"},{"issue":"7","key":"key-10.2471\/BLT.17.198879-201712271617-R28","first-page":"494","article-title":"Mutagenic and teratogenic effects of anti-schistosomal praziquantel.","volume":"95","author":"Ni","year":"1982","journal-title":"Chin Med J (Engl)"},{"issue":"2-3","key":"key-10.2471\/BLT.17.198879-201712271617-R29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0001-706X(03)00033-0","article-title":"Administration of praziquantel to pregnant and lactating women.","volume":"86","author":"Olds","year":"2003","journal-title":"Acta Trop"},{"key":"key-10.2471\/BLT.17.198879-201712271617-R30","unstructured":"Report of the WHO Informal Consultation on the use of praziquantel during pregnancy lactation and albendazole\/mebendazole in children under 24 months. Geneva: World Health Organization; 2003. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/68041\/1\/WHO_CDS_CPE_PVC_2002.4.pdf[cited 2017 Nov 20]."},{"issue":"9","key":"key-10.2471\/BLT.17.198879-201712271617-R31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1471-4922(02)02386-3","article-title":"New policies for using anthelmintics in high risk groups.","volume":"18","author":"Allen","year":"2002","journal-title":"Trends Parasitol"},{"issue":"4","key":"key-10.2471\/BLT.17.198879-201712271617-R32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/649924","article-title":"Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial.","volume":"50","author":"Ndibazza","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"key-10.2471\/BLT.17.198879-201712271617-R33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1017\/S0022149X13000643","article-title":"Urogenital schistosomiasis in women of reproductive age and pregnant mothers in Kwale County, Kenya.","volume":"89","author":"Kihara","year":"2015","journal-title":"J Helminthol"},{"issue":"1","key":"key-10.2471\/BLT.17.198879-201712271617-R34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13071-015-1244-0","article-title":"Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey.","volume":"9","author":"Knopp","year":"2016","journal-title":"Parasit Vectors"},{"issue":"5","key":"key-10.2471\/BLT.17.198879-201712271617-R35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1473-3099(16)30009-3","article-title":"Praziquantel for schistosomiasis in pregnancy.","volume":"16","author":"Qian","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"key-10.2471\/BLT.17.198879-201712271617-R36","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1093\/cid\/cis976","article-title":"Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial.","volume":"56","author":"Basra","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R37","doi-asserted-by":"publisher","first-page":"e2724","DOI":"10.1371\/journal.pntd.0002724","article-title":"The association of parasitic infections in pregnancy and maternal and fetal anemia: a cohort study in coastal Kenya.","volume":"8","author":"McClure","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"key-10.2471\/BLT.17.198879-201712271617-R38","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1017\/S0031182011001053","article-title":"Treatment with anthelminthics during pregnancy: what gains and what risks for the mother and child?","volume":"138","author":"Elliott","year":"2011","journal-title":"Parasitology"},{"issue":"9","key":"key-10.2471\/BLT.17.198879-201712271617-R39","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.trstmh.2004.01.001","article-title":"Is praziquantel therapy safe during pregnancy?","volume":"98","author":"Adam","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/jtm.12165","article-title":"Schistosomiasis in pregnant travellers: a case series.","volume":"22","author":"Ben-Chetrit","year":"2015","journal-title":"J Travel Med"},{"issue":"1","key":"key-10.2471\/BLT.17.198879-201712271617-R41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1179\/136485905X17407","article-title":"Praziquantel for the treatment of schistosomiasis mansoni during pregnancy.","volume":"99","author":"Adam","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R42","first-page":"91","article-title":"Case report: neurocysticercosis in pregnancy.","volume":"93","author":"Paparone","year":"1996","journal-title":"N J Med"},{"issue":"3","key":"key-10.2471\/BLT.17.198879-201712271617-R43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1399-3038.2010.01122.x","article-title":"Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results.","volume":"22","author":"Mpairwe","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"key-10.2471\/BLT.17.198879-201712271617-R44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/pai.12719","article-title":"Life-course of atopy and allergy-related disease events in tropical sub-Saharan Africa: A birth cohort study.","volume":"28","author":"Lule","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"key-10.2471\/BLT.17.198879-201712271617-R45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1086\/422604","article-title":"Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel.","volume":"190","author":"Joseph","year":"2004","journal-title":"J Infect Dis"},{"issue":"8","key":"key-10.2471\/BLT.17.198879-201712271617-R46","doi-asserted-by":"publisher","first-page":"e0003995","DOI":"10.1371\/journal.pntd.0003995","article-title":"CD4+CD25hiFOXP3+ regulatory T cells and cytokine responses in human schistosomiasis before and after treatment with praziquantel.","volume":"9","author":"Schmiedel","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"key-10.2471\/BLT.17.198879-201712271617-R47","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1128\/IAI.01072-10","article-title":"Maternal schistosomiasis japonica is associated with maternal, placental, and fetal inflammation.","volume":"79","author":"Kurtis","year":"2011","journal-title":"Infect Immun"},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1473-3099(15)00345-X","article-title":"Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial.","volume":"16","author":"Olveda","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.2471\/BLT.17.198879-201712271617-R49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy.","volume":"5","author":"Costantine","year":"2014","journal-title":"Front Pharmacol"},{"issue":"11","key":"key-10.2471\/BLT.17.198879-201712271617-R50","doi-asserted-by":"publisher","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review.","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"issue":"3","key":"key-10.2471\/BLT.17.198879-201712271617-R51","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/infdis\/157.3.530","article-title":"Praziquantel pharmacokinetics and side effects in schistosoma japonicum-infected patients with liver disease.","volume":"157","author":"Watt","year":"1988","journal-title":"J Infect Dis"},{"key":"key-10.2471\/BLT.17.198879-201712271617-R52","first-page":"1137","article-title":"Results of toxicological studies on praziquantel.","volume":"34","author":"Frohberg","year":"1984","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"key-10.2471\/BLT.17.198879-201712271617-R53","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4269\/ajtmh.2011.10-0585","article-title":"Urogenital schistosomiasis in women of reproductive age in Tanzania\u2019s Lake Victoria region.","volume":"84","author":"Downs","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.2471\/BLT.17.198879-201712271617-R54","unstructured":"Schistosomiasis. Strategy. Control and preventive chemotherapy [internet] Geneva: World Health Organization; 2017. Available from: http:\/\/www.who.int\/schistosomiasis\/strategy\/en\/[cited 2017 Nov 15]."},{"issue":"2","key":"key-10.2471\/BLT.17.198879-201712271617-R55","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S1473-3099(16)30475-3","article-title":"Human schistosomiasis in the post mass drug administration era.","volume":"17","author":"Mutapi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.2471\/BLT.17.198879-201712271617-R56","unstructured":"The pregnancy and lactation labeling rule (PLLR). Silver Spring: United States Food and Drug Administration; 2016. Available from: https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/Labeling\/ucm093307.htm [cited 2017 Nov 15]."}],"container-title":["Bulletin of the World Health Organization"],"original-title":[],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:20:05Z","timestamp":1742404805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5791873\/pdf\/BLT.17.198879.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,11,27]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.2471\/blt.17.198879","relation":{},"ISSN":["0042-9686"],"issn-type":[{"value":"0042-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11,27]]}}}